EUVIMEDEUVIMED entdecken
Crossref

Phospholipase A2 receptor-positive membranous nephropathy detected by laser microdissection and mass spectrometry in patients negative by immunofluorescence for phospholipase A2 receptor on kidney biopsy

Ladan Zand, Ilario Russo, Maria J Vargas-Brochero, Samih H Nasr, Benjamin Madden, Jason D Theis, Fernando C Fervenza, Sanjeev Sethi

Kidney International · 2025

DOI: 10.1016/j.kint.2025.04.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2025. Verfasst von Ladan Zand und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Glomerulonephritis, Membranous, Receptors, Phospholipase A2, Laser Capture Microdissection, Kidney. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Membranous nephropathy (MN) is characterized by subepithelial deposition of immune complexes along the glomerular basement membrane. The muscle-type phospholipase A2 receptor (PLA2R) has been identified as the principal antigen in MN, and its detection via immunofluorescence (IF) studies remains a diagnostic cornerstone. Advancements, including laser microdissection/mass spectrometry (LMD/MS), offer enhanced sensitivity for antigen identification, independent of epitope accessibility. METHODS: A cohort of 250 kidney biopsy samples (discovery cohort) diagnosed as PLA2R-negative MN by IF underwent LMD/MS analysis for antigen detection. Biopsies were microdissected, and peptides were analyzed using high-performance liquid chromatography coupled with mass spectrometry. Total spectral counts greater than 10 are considered positive for PLA2R-associated MN. RESULTS: LMD/MS identified PLA2R antigen in seven (2.8%) cases classified as PLA2R-negative by IF. The mean total spectral count in the seven cases was 55. Additionally, LMD/MS detected another two positive cases in PLA2R-negative MN from a recently validated clinical test for antigen detection. The mean total spectral count in these two cases was 189. All nine cases showed significant IgG along the glomerular basement membrane. Electron microscopy showed stage II MN in seven of the nine cases, one case showed stage I, and the other showed stage III-IV MN. Serologic studies showed anti-PLA2R antibodies in two of seven cases with available data. CONCLUSIONS: A small subset of PLA2R-negative MN by IF became PLA2R-positive by LMD/MS. Our study emphasizes the importance of not ruling out the possibility of PLA2R-associated MN in patients with negative IF staining for PLA2R. LMD/MS is an important diagnostic test for MN antigen detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, MembranousReceptors, Phospholipase A2Laser Capture MicrodissectionKidneyAutoantigensHumansMaleMiddle AgedFemaleBiopsyAdultFluorescent Antibody TechniqueAgedMass SpectrometryChromatography, High Pressure LiquidAutoantibodies

Stichwörter der Autor:innen

immunofluorescencemass spectrometrymembranous nephropathyphospholipase A2 receptor

Substanzen

Receptors, Phospholipase A2PLA2R1 protein, humanAutoantigensAutoantibodies

Autor:innen und Institutionen

  • Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA; Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, Bari, Italy.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Mayo Clinic Proteomics Core, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: sethi.sanjeev@mayo.edu.

Zitieren

APA

Zand, L., Russo, I., Vargas-Brochero, M. J., Nasr, S. H., Madden, B., Theis, J. D., Fervenza, F. C., & Sethi, S. (2025). Phospholipase A2 receptor-positive membranous nephropathy detected by laser microdissection and mass spectrometry in patients negative by immunofluorescence for phospholipase A2 receptor on kidney biopsy. Kidney International. https://doi.org/10.1016/j.kint.2025.04.032

Vancouver

Zand L, Russo I, Vargas-Brochero MJ, Nasr SH, Madden B, Theis JD, et al. Phospholipase A2 receptor-positive membranous nephropathy detected by laser microdissection and mass spectrometry in patients negative by immunofluorescence for phospholipase A2 receptor on kidney biopsy. Kidney International. 2025. doi:10.1016/j.kint.2025.04.032

BibTeX
@article{Zand2025,
  author = {Zand, Ladan and Russo, Ilario and Vargas-Brochero, Maria J and Nasr, Samih H and Madden, Benjamin and Theis, Jason D and Fervenza, Fernando C and Sethi, Sanjeev},
  title = {Phospholipase A2 receptor-positive membranous nephropathy detected by laser microdissection and mass spectrometry in patients negative by immunofluorescence for phospholipase A2 receptor on kidney biopsy},
  journal = {Kidney International},
  year = {2025},
  doi = {10.1016/j.kint.2025.04.032}
}
Kostenlos starten →